NovoCure Ltd Quarterly Weighted Average Number of Shares Outstanding, Basic from Q3 2018 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
NovoCure Ltd quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q3 2018 to Q3 2024.
  • NovoCure Ltd Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 108M shares, a 1.38% increase year-over-year.
  • NovoCure Ltd annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 106M shares, a 1.65% increase from 2022.
  • NovoCure Ltd annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 105M shares, a 1.19% increase from 2021.
  • NovoCure Ltd annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 103M shares, a 2.48% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 108M +1.47M +1.38% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-30
Q2 2024 108M +1.41M +1.33% Apr 1, 2024 Jun 30, 2024 10-Q 2024-07-25
Q1 2024 107M +1.6M +1.51% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 106M +1.36M +1.3% Oct 1, 2023 Dec 31, 2023 10-Q 2024-10-30
Q3 2023 107M +1.89M +1.8% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-30
Q2 2023 106M +1.66M +1.59% Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-25
Q1 2023 106M +1.48M +1.42% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 105M +1.14M +1.1% Oct 1, 2022 Dec 31, 2022 10-K 2023-02-23
Q3 2022 105M +1.15M +1.11% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-26
Q2 2022 105M +1.14M +1.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-07-27
Q1 2022 104M +1.55M +1.51% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 104M +1.94M +1.9% Oct 1, 2021 Dec 31, 2021 10-K 2023-02-23
Q3 2021 104M +2.5M +2.47% Jul 1, 2021 Sep 30, 2021 10-K 2023-02-23
Q2 2021 103M +2.77M +2.75% Apr 1, 2021 Jun 30, 2021 10-K 2023-02-23
Q1 2021 103M +2.76M +2.76% Jan 1, 2021 Mar 31, 2021 10-K 2023-02-23
Q4 2020 102M +2.72M +2.74% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-23
Q3 2020 101M +2.75M +2.79% Jul 1, 2020 Sep 30, 2020 10-K 2023-02-23
Q2 2020 101M +4.36M +4.53% Apr 1, 2020 Jun 30, 2020 10-K 2023-02-23
Q1 2020 99.9M +5.07M +5.34% Jan 1, 2020 Mar 31, 2020 10-K 2023-02-23
Q4 2019 99.2M Oct 1, 2019 Dec 31, 2019 10-K 2022-02-24
Q3 2019 98.5M +5.57M +6% Jul 1, 2019 Sep 30, 2019 10-K 2022-02-24
Q2 2019 96.4M Apr 1, 2019 Jun 30, 2019 10-K 2022-02-24
Q1 2019 94.8M Jan 1, 2019 Mar 31, 2019 10-K 2022-02-24
Q3 2018 92.9M Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.